BESPONSA (inotuzumab ozogamicin) for the Treatment of Acute Lymphoblastic Leukaemia
BESPONSA® is an intravenous infusion indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).
Pharmaceutical and Biotech Industries Regulatory and Management Consulting Services
81 Shepherds Hill, Suite 8,
London,
N6 5RG Other,
United Kingdom
Turio was established in 2004 and is an international consulting company for the pharmaceutical industry, based in London, UK. The company offers a comprehensive range of scientific, technical, regulatory and management services to pharmaceutical, biotech and private investing companies.
Advice and support is provided by a team of core independent consultants, recognised experts in their field. They collectively have several decades of scientific and regulatory experience in the pharmaceutical, biotech and national agencies within EU and US FDA. The highly qualified team is assisted by a network of professionals which cover all areas of pharmaceutical and biotechnology expertise.
Our experts have been particularly successful in assisting clients in Central Eastern European and Asian countries, the EU, as well as the US.
Examples of completed projects:
Turio offer a strategic regulatory consulting service providing advice on appropriate regulatory strategy, recommending the best route to the market and preparation of briefing packages for pre-submission meetings with EMEA and FDA
Turio can also assist with preparation and compilation of CTD and submission to RA authorities worldwide, including, US, EU and other national agencies. Turio offer expert report authoring of pharmaceuticals and pre-clinical modules.
The service also offers assistance in communicating with national agencies and preparing for RA meetings with agency officials on application issues.
BESPONSA® is an intravenous infusion indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).
Adlyxin (lixisenatide) is an injectable solution developed by Sanofi for the treatment of type 2 diabetes in adults.
81 Shepherds Hill, Suite 8
London
N6 5RG
Other
United Kingdom